Back to Journals » Cancer Management and Research » Volume 11

Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data

Total article views   Abstract views HTML views PDF downloads Totals
3,726 Dovepress* 2,541 710+ 801 3,251
PubMed Central* 0 475 252 475
Totals 2,541 1,185 1,053 3,726
*Since 20 March 2019
+Since July 2016

View citations on PubMed Central and Google Scholar